BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11480781)

  • 1. Modulation of fetal hemoglobin in sickle cell anemia.
    Steinberg MH
    Hemoglobin; 2001 May; 25(2):195-211. PubMed ID: 11480781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal hemoglobin in sickle cell anemia: The Arab-Indian haplotype and new therapeutic agents.
    Habara AH; Shaikho EM; Steinberg MH
    Am J Hematol; 2017 Nov; 92(11):1233-1242. PubMed ID: 28736939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic modulation of fetal hemoglobin in hydroxyurea-treated sickle cell anemia.
    Aleluia MM; Santiago RP; da Guarda CC; Fonseca TC; Neves FI; Quinto RS; Figueiredo CV; Yahouédéhou SC; Oliveira RM; Ferreira JR; Cerqueira BA; Barbosa CG; Milton JN; Steinberg MH; de Souza Gonçalves M
    Am J Hematol; 2017 May; 92(5):E70-E72. PubMed ID: 28195442
    [No Abstract]   [Full Text] [Related]  

  • 4. Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease.
    Steinberg MH; Voskaridou E; Kutlar A; Loukopoulos D; Koshy M; Ballas SK; Castro O; Barton F
    Am J Hematol; 2003 Feb; 72(2):121-6. PubMed ID: 12555216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal hemoglobin in sickle cell anemia.
    Akinsheye I; Alsultan A; Solovieff N; Ngo D; Baldwin CT; Sebastiani P; Chui DH; Steinberg MH
    Blood; 2011 Jul; 118(1):19-27. PubMed ID: 21490337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sickle cell anemia: targeting the role of fetal hemoglobin in therapy.
    Coleman E; Inusa B
    Clin Pediatr (Phila); 2007 Jun; 46(5):386-91. PubMed ID: 17556734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hydroxyurea on hemoglobin F and water content in the red blood cells of dogs and of patients with sickle cell anemia.
    Orringer EP; Blythe DS; Johnson AE; Phillips G; Dover GJ; Parker JC
    Blood; 1991 Jul; 78(1):212-6. PubMed ID: 1712641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of pathophysiology and rationale for treatment of sickle cell anemia.
    Rodgers GP
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):2-7. PubMed ID: 9317195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of fetal hemoglobin production by hydroxyurea in sickle cell anemia.
    Dover GJ; Charache S
    Prog Clin Biol Res; 1989; 316B():295-306. PubMed ID: 2482499
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological induction of fetal hemoglobin in sickle cell disease and beta-thalassemia.
    Atweh GF; Loukopoulos D
    Semin Hematol; 2001 Oct; 38(4):367-73. PubMed ID: 11605172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal hemoglobin and hydroxycarbamide moduate both plasma concentration and cellular origin of circulating microparticles in sickle cell anemia children.
    Nébor D; Romana M; Santiago R; Vachiery N; Picot J; Broquere C; Chaar V; Doumdo L; Odièvre MH; Benkerrou M; Elion J
    Haematologica; 2013 Jun; 98(6):862-7. PubMed ID: 23403312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sickle cell disease severity: an introduction.
    Pace BS; Goodman SR
    Exp Biol Med (Maywood); 2016 Apr; 241(7):677-8. PubMed ID: 27190296
    [No Abstract]   [Full Text] [Related]  

  • 13. Heterogeneity of fetal hemoglobin production in adult red blood cells.
    Khandros E; Blobel GA
    Curr Opin Hematol; 2021 May; 28(3):164-170. PubMed ID: 33631783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyurea: specific therapy for sickle cell anemia?
    Kaufman RE
    Blood; 1992 May; 79(10):2503-6. PubMed ID: 1375102
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydroxyurea and sickle cell disease.
    Orringer EP; Parker JC
    Hematol Pathol; 1992; 6(4):171-8. PubMed ID: 1283391
    [No Abstract]   [Full Text] [Related]  

  • 16. The biophysics of sickle cell hydroxyurea therapy.
    Eaton WA; Hofrichter J
    Science; 1995 May; 268(5214):1142-3. PubMed ID: 7539154
    [No Abstract]   [Full Text] [Related]  

  • 17. Hydroxyurea induction of fetal hemoglobin synthesis in sickle-cell disease.
    Dover GJ; Charache S
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):61-6. PubMed ID: 1379374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sickle cell anemia and fetal hemoglobin.
    Steinberg MH
    Am J Med Sci; 1994 Nov; 308(5):259-65. PubMed ID: 7526687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic manipulation of fetal hemoglobin. Update on clinical trials with hydroxyurea.
    Dover GJ
    Ann N Y Acad Sci; 1990; 612():184-90. PubMed ID: 1705407
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathophysiology and recent therapeutic insights of sickle cell disease.
    Shah F; Dwivedi M
    Ann Hematol; 2020 May; 99(5):925-935. PubMed ID: 32157419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.